SCHEMBL22924131

SCHEMBL22924131

Cc1ccc2[nH]ncc2c1C(C)(C)Cc1nn(C2CC2)c2c(C(C)(C)C)c(F)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24089313 0.78 — —
SCHEMBL26578040 0.74 — —
SCHEMBL21024009 0.71 AXL (0.34) —
SCHEMBL18408609 0.71 — —
SCHEMBL25724223 0.70 MAPT (0.33) —
SCHEMBL17030763 0.69 AXL (0.42) —
SCHEMBL17030759 0.68 IDO1 (0.41) —
SCHEMBL22924180 0.67 — —
SCHEMBL21734001 0.67 NOS1 (0.32) —
SCHEMBL21938210 0.67 IDO1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024501-A1 COVALENT INHIBITORS OF KRAS ARAXES PHARMA LLC 2021-01-28 — — US disclosed
Send feedback